BioMap
Signal active
Organization
Contact Information
Overview
Founded in 2020 by Robin Li and Wei Liu, BioMap is a disruptive life science AI company responsible for building xTrimo, the first and largest protein-centric large language model platform. Their technology allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. Supported by an international, cross-functional team of over 300 experts, BioMap is solving critical, protein-related drug development problems and charting a course to radically improve patients’ lives.
About
Industries
Artificial Intelligence (AI), Life Science, Generative AI, Precision Medicine
Founded
2020
Employees
251-500
Headquarters locations
United States, North America
Social
N/A
Profile Resume
BioMap headquartered in United States, North America, operates in the Artificial Intelligence (AI), Life Science, Generative AI, Precision Medicine sector. The company focuses on Artificial Intelligence (AI) and has secured $3.2B in funding across 32 round(s). With a team of 251-500 employees, BioMap is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Venture Round - BioMap, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$100.0M
Details
1
BioMap has raised a total of $100.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 100.0M |
Investors
BioMap is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Verity venture | - | FUNDING ROUND - Verity venture | 100.0M |
| BioMap | - | FUNDING ROUND - BioMap | 100.0M |
| BlueRun Ventures | - | FUNDING ROUND - BlueRun Ventures | 100.0M |
| BioMap | - | FUNDING ROUND - BioMap | undefined |
Recent Activity
There is no recent news or activity for this profile.